Sui Network faces a mainnet outage, leaving transactions stalled for over two hours while SUI price remains flat amidst market rally. The Sui Network has been facingSui Network faces a mainnet outage, leaving transactions stalled for over two hours while SUI price remains flat amidst market rally. The Sui Network has been facing

Sui Network Faces Outage as Mainnet Stalls with Flat SUI Price

Sui Network faces a mainnet outage, leaving transactions stalled for over two hours while SUI price remains flat amidst market rally.

The Sui Network has been facing a significant issue as its mainnet stalls, leaving transactions unable to process.

This outage has caused a flat SUI price, which has not reacted to the overall bullish trend in the broader cryptocurrency market.

The Sui team is aware of the problem and is actively working on a solution, but the network remains down for now.

Sui Network Faces Stalls and Transaction Delays

The Sui mainnet has stalled for over two hours, preventing new transactions from being processed.

The last transaction occurred more than two hours ago, according to the network’s explorer data. The team has confirmed that no new blocks have been produced during this period.

Sui’s developers have acknowledged the issue and are working to resolve it.

They have stated that decentralized applications (dApps) like Slush and SuiScan may be unavailable for some time.

Users may also experience slow or unprocessed transactions as the network continues to face disruptions.

Despite the current technical problems, the Sui team has assured users that no funds are at risk.

The outage is believed to be caused by a validator consensus failure, and work is underway to restore the network to normal operation.

However, the team has warned that delays should be expected until the issue is fixed.

SUI Price Remains Flat Amidst Broader Market Rally

While Bitcoin and other cryptocurrencies are seeing price increases, the SUI price has remained largely flat.

This stagnant price action comes as a result of the network outage, which has left users and traders uncertain.

Despite the broader market’s positive momentum, SUI’s price has not shown significant movement.

This lack of movement in the SUI price could be a reflection of hesitation among investors.

With the network experiencing technical issues, many might be waiting for stability before making any decisions.

Consequently, the price has not dropped sharply but has also failed to rise along with the rest of the market.

It’s clear that the performance of SUI is tied to the health of the network.

Investors are closely watching the situation, and the next few days may reveal how much the outage impacts the price.

If the team resolves the issue promptly, SUI may return to its upward trajectory.

Related Reading:  Sui Ecosystem Gains Spotlight as Taipei Builders Demo Day Highlights New DeFi Ideas

Previous Outages and Network Stability Concerns

This is the second major outage for the Sui Network, with the first occurring in November 2025.

That outage also lasted for just over two hours, causing similar concerns among users.

Though both incidents are unrelated, they highlight the challenges Sui faces in maintaining network stability.

Other major blockchain networks, such as Solana, have experienced outages as well.

These types of issues are not uncommon in the blockchain space, particularly for new networks.

However, frequent downtimes can hurt user confidence and may delay the growth of the network.

Sui’s ability to recover quickly from this outage will be important for its long-term reputation.

If the team can resolve the issue and prevent future outages, the network may continue to gain traction.

However, ongoing instability could raise concerns for potential users and investors.

The post Sui Network Faces Outage as Mainnet Stalls with Flat SUI Price appeared first on Live Bitcoin News.

Market Opportunity
SUI Logo
SUI Price(SUI)
$1.7887
$1.7887$1.7887
-0.82%
USD
SUI (SUI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26